Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.


Topic: Press release summary
Source: Eminence Business Media


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 27, 2026 19:40 HKT/SGT
Xunce Technology's Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?  
Mar 27, 2026 19:19 HKT/SGT
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility  
Friday, March 27, 2026 6:44:00 PM
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million  
Mar 27, 2026 18:38 HKT/SGT
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency  
Friday, March 27, 2026 5:19:00 PM
New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation  
Friday, March 27, 2026 3:51:00 PM
Modern Dental Group Announces 2025 Annual Results, Net Profit Surges 47.7% on Digitalization-Driven Operational Efficiency Gains  
Mar 27, 2026 15:43 HKT/SGT
Thailand Cat Lovers Fair 2026 Returns with Immersive "MEOW LAND" Experience  
Mar 27, 2026 15:33 HKT/SGT
JF SmartInvest Holdings Ltd Adjusted Profit Leaps 191.8% to RMB1.02 Billion 'Technology + Investment Research' Dual-Driver Strategy Delivers Remarkable Results, Overseas Expansion Ushers in a New Chapter of Globalisation  
Mar 27, 2026 15:02 HKT/SGT
How to Choose the Right Savings Account for Your Money Goals in Singapore  
Mar 27, 2026 14:20 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: